Phoenix Biotech Acquisition Corp. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

6.83 M

Shareholding (Mar 2025)

FII

0.16%

Held by 6 FIIs

DII

98.55%

Held by 1 DIIs

Promoter

0.78%

How big is Phoenix Biotech Acquisition Corp.?

22-Jun-2025

As of Jun 18, Phoenix Biotech Acquisition Corp. has a market capitalization of 3.00 million and reported net sales of 0.00 million, with a net profit of -11.20 million over the last four quarters. The balance sheet shows shareholder's funds of -0.60 million and total assets of 7.50 million.

What does Phoenix Biotech Acquisition Corp. do?

22-Jun-2025

Phoenix Biotech Acquisition Corp. is a micro-cap finance company with a recent net profit loss of $5 million and a market cap of $3 million. It has no dividend yield and a highly negative debt equity ratio.

Is Phoenix Biotech Acquisition Corp. technically bullish or bearish?

20-Sep-2025

As of July 28, 2025, Phoenix Biotech Acquisition Corp. shows a mildly bullish trend based on weekly MACD and daily moving averages, but mixed signals from monthly RSI and Bollinger Bands suggest caution due to significant underperformance compared to the S&P 500.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Finance

Market cap

USD 9 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-999,999.00

Return on Equity

866.79%

Price to Book

-5.95

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-5 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-98.66%

6 Months

-89.31%

1 Year

-98.83%

2 Years

-99.13%

3 Years

-99.06%

4 Years

0.0%

5 Years

0.0%

Phoenix Biotech Acquisition Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Phoenix Biotech Acquisition Corp. technically bullish or bearish?

As of 28 July 2025, the technical trend for Phoenix Biotech Acquisition Corp. has changed from mildly bearish to mildly bullish. The weekly MACD indicates a mildly bullish stance, while the daily moving averages also support this bullish outlook. However, the monthly RSI remains bearish, and the Bollinger Bands and KST show bearish signals on both weekly and monthly time frames. Dow Theory suggests a mildly bullish trend on the monthly chart, but the overall indicators present mixed signals. In terms of performance, the stock has underperformed significantly compared to the S&P 500 across multiple periods, with a 1-month return of -38.3% versus the S&P 500's 2.33%, and a 1-year return of -32.96% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, but caution is warranted due to the mixed indicators and poor relative performance....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

-200.98%

EBIT to Interest (avg)

-4.32

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

0.27%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

24.78%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-1.38

EV to EBIT

0.18

EV to EBITDA

0.19

EV to Capital Employed

0.64

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

364.82%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bullish

Bearish

Bollinger Bands

Bearish

Sideways

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 2 Schemes (0.51%)

Foreign Institutions

Held by 6 Foreign Institutions (0.16%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -125.00% vs -71.43% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.50",
          "val2": "-4.90",
          "chgp": "8.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.70",
          "val2": "3.30",
          "chgp": "-121.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.40",
          "val2": "-2.40",
          "chgp": "-125.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -232.00% vs -257.14% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-15.00",
          "val2": "-2.90",
          "chgp": "-417.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.30",
          "val2": "-2.50",
          "chgp": "-232.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-4.50

-4.90

8.16%

Interest

0.00

Exceptional Items

-0.70

3.30

-121.21%

Consolidate Net Profit

-5.40

-2.40

-125.00%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -125.00% vs -71.43% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-15.00

-2.90

-417.24%

Interest

0.00

Exceptional Items

8.50

0.00

Consolidate Net Profit

-8.30

-2.50

-232.00%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -232.00% vs -257.14% in Dec 2023

All Annual Results

Company CV

About Phoenix Biotech Acquisition Corp.

Phoenix Biotech Acquisition Corp.

Finance

No Details Available.

Company Coordinates

No Company Details Available

Phoenix Biotech Acquisition Corp.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Phoenix Biotech Acquisition Corp.?

Watch in Real-Time

What does Phoenix Biotech Acquisition Corp. do?

Is Phoenix Biotech Acquisition Corp. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Phoenix Biotech Acquisition Corp. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Phoenix Biotech Acquisition Corp.

Company Coordinates